Lymphoma Clinical Trials

Completed

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

NCT00068523

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

NCT00054236

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +75 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only

NCT00451178

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntsville, Alabama, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenbrae, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palm Springs, California, United States

View all 25 locations

View Trial Details

Completed

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00345865

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

NCT01329900

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT01902225

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of California, San Francisco San Francisco, California, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger

NCT00290498

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials

NCT02948413

Conditions: Adenoma, Genital Diseases, Genital Diseases, Male, +21 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)

NCT02504190

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Mohamad Mohty Paris, France

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions